Title:
MAMMAL CTLA-8 AND NEW USE OF RELATED MEDICINE
Document Type and Number:
Japanese Patent JP2002145799
Kind Code:
A
Abstract:
To provide the solution of a problem related to a wide range of denaturation states or other states affecting immune systems, hematopoietic cells and other type cells by the discovery and characterization of specific cytokines and their physiological effects.
There is provided a composition selected from the group consisting of: (a) a composition comprising a mammal G-CSF and a mammal CTLS-8, and (b) a composition comprising a mammal CTLA-8, and a mammal IL-6.
More Like This:
| WO/2019/099440 | MULTIFUNCTIONAL IMMUNE CELL THERAPIES |
| WO/2001/087321 | GLYCOSYLTRANSFERASE PROTEINS |
| JP2652534 | [Title of Invention] Recombinant Inhibin |
Inventors:
BANCHEREAU JACQUES
DJOSSOU ODILE
FLORES-ROMO LEOPOLDO
FOSSIEZ FRANCOIS
GOLSTEIN PIERRE
KRISHNA MALA
LEBECQUE SERGE J E
MURRAY RICHARD
DJOSSOU ODILE
FLORES-ROMO LEOPOLDO
FOSSIEZ FRANCOIS
GOLSTEIN PIERRE
KRISHNA MALA
LEBECQUE SERGE J E
MURRAY RICHARD
Application Number:
JP2001275810A
Publication Date:
May 22, 2002
Filing Date:
October 23, 1996
Export Citation:
Assignee:
SCHERING PLOUGH CORP
INST NAT SANTE RECH MED
INST NAT SANTE RECH MED
International Classes:
A61K38/00; A61K38/19; A61P7/00; A61P31/00; A61P31/04; A61P31/12; C07K14/52; C07K14/535; C07K14/54; C12P21/02; C12N15/09; C12R1/91; (IPC1-7): A61K38/00; A61P7/00; A61P31/04; A61P31/12; C07K14/52; C07K14/535; C07K14/54
Attorney, Agent or Firm:
Shusaku Yamamoto
Previous Patent: MATERIAL COMPRISING HYDROGEL AND USED FOR CELL TRANSPLANTATION THERAPY
Next Patent: WOUND MEDICINE
Next Patent: WOUND MEDICINE